What we do

PRI – Pediatric Research International – is a highly specialized organization to close the gap between pharmaceutical industry and academic clinical research. With over 10 years of experience in different fields and partnerships across 17 countries, we collaborate with pharmaceutical companies and academic partners in pediatric drug development – precisely adapted to scientific and commercial requirements. In a model that breaks with tradition, in a model that fits your needs.

Pediatric Research meeting highests standards

Our core competency lies in the operational and scientific execution of clinical studies and trials in severe pediatric diseases. Our focus is on pediatric oncology, our work goes above and beyond. The team behind PRI brings together decades of hands-on experience in pediatric research – across more than 20 clinical studies and certified to the highest GCP standards. In 2025, we took the next step and launched our first self-sponsored clinical trial in a new model in collaboration with a US-based pharmaceutical partner. PRI delivers what pharmaceutical companies need most: research built to the highest regulatory standards and designed around what is realistically achievable.

Some of our most valuable insights – on sponsoring models, patient populations, clinical infrastructure, and much more – are reserved for qualified partners.

Sign our NDA and take the first step towards a partnership built on trust and transparency.